At a glance
- Half-life
- 6.9 hours, the mean terminal elimination half-life after oral dosing in rats in the cited study (3.8 hours after intravenous dosing); no human value.[1]
- Route
- Intravenous and oral dosing in rats, and subcutaneous injection in mice, in the cited studies.[1][2]
- Category
- Cellular research
- Vial size
- Not listed
The half-life on this card and the bioavailability in the text are from a rat study. The time to peak is a library estimate. Nothing on the card describes human absorption or a capsule product.[1]
What the research says
NNMT methylates nicotinamide and is overexpressed in some tissues, such as adipose tissue and skeletal muscle, in disease states. A 2018 laboratory and mouse study tested a series of methylquinolinium NNMT inhibitors for membrane permeability, enzyme selectivity and effects in cultured fat cells. The inhibitors lowered the reaction product 1-methylnicotinamide and raised intracellular NAD+ in those cells.[1][2]
In the same work, diet-induced obese mice given 5-amino-1MQ by subcutaneous injection three times a day for 11 days (9 per group) lost body weight and white adipose mass compared with saline controls while on a high-fat diet. These are animal endpoints measured under laboratory feeding conditions. The paper does not report a human exposure, and its subcutaneous route in mice differs from the oral route the library uses.[2]
A separate 2021 study validated an assay for 5-Amino-1MQ in rat plasma and urine and applied it to intravenous and oral dosing in rats. It reports a mean terminal half-life of about 3.8 hours after intravenous dosing and 6.9 hours after oral dosing, with oral bioavailability of about 38.4%. Those rat values are the basis of the library's oral model.[1]
Amounts
The library lists no product amount, capsule strength or vial for 5-Amino-1MQ, and neither cited study reports a human amount. This guide therefore gives no milligram figure for people. An oral entry in a tracker is recorded in the milligrams printed on whatever product label the user holds.[1][2]
No human dose has been established.
Open the calculator for amount conversionsHalf-life and timing
6.9 hours, the mean terminal elimination half-life after oral dosing in rats in the cited study (3.8 hours after intravenous dosing); no human value.[1]
Continue to the calculatorReconstitution
5-Amino-1MQ is logged as an oral entry, so there is no powder, no added water and no syringe-unit step. The arithmetic is a product of label strength and count: milligrams per capsule multiplied by the number taken gives the milligram entry. Because no sourced product strength exists in the library, this guide leaves that strength as a variable rather than inventing one.
Tracking it in PinPoint
From a reference to a record
Built for peptide, TRT, and GLP-1 schedules. Set up your vial in seconds, log every dose, and see your modeled levels between doses. Track vials and prefilled pens side by side.[3]
The Home curve models your levels between doses from an estimate built on the half-life value stored for each compound, published where a published value exists and an estimate where none does. Drag to scrub modeled values at any timestamp, or preview 30 days of a dose pattern. Ask PinPoint provides educational reference with sources; it never recommends a dose or a schedule change. These features record and visualize entered information, with the limits of each compound's source data still applying.
Get PinPoint on the App StoreFrequently asked questions
- Is the 5-Amino-1MQ half-life a human number?
- No. The 6.9 hour value is the oral apparent half-life measured in rats. The library uses it because it models the oral route, and labels the entry as preclinical. The shorter 3.8 hour value from the same study belongs to intravenous dosing in rats.[1]
- Why does the 5-Amino-1MQ guide link to the general calculator?
- The calculator converts powder vials into concentration and syringe units. An oral capsule entry has no reconstitution step, so no compound-specific calculator route is generated for it. The general calculator remains available for injectable compounds logged alongside it.
- Which 5 amino 1mq study measured oral bioavailability?
- The 2021 rat pharmacokinetics study compared intravenous and oral dosing and reported oral bioavailability of about 38.4%. It is the only source in the library for that figure, and it concerns rats rather than people.[1]
- Is 5 amino 1mq a peptide?
- No. 5-Amino-1MQ is 5-amino-1-methylquinolinium, a small-molecule NNMT inhibitor. It sits in the same app library as peptides, but it has no amino-acid chain.[1]
- Is there a human 5 amino 1mq dosage?
- No human dose has been established. The cited studies dosed rats and mice.[1][2]
Sources
Sources checked against the cited documents on 19 November 2026.
- PubMed rat pharmacokinetics study 34304009Published 2021 in a pharmaceutical and biomedical analysis journal. Oral and intravenous half-life and oral bioavailability checked against the abstract on 19 November 2026; the full text is paywalled.Retrieved 2026-11-19 · library-reference
- PubMed mouse obesity study 29155147Published 2018 in a biochemical pharmacology journal. Methylquinolinium NNMT inhibitor series in cultured adipocytes and diet-induced obese mice; abstract and open-access full text (PMC5826726) read 19 November 2026.Retrieved 2026-11-19 · primary-reference
- PinPoint App Store descriptionFeature wording from the approved application description, not pricing.Retrieved 2026-10-05 · app-description
